Aquestive Therapeutics, Inc. 10-Q filing
Filed 2026-05-13 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001398733-26-000030
- Form type
- 10-Q
- CIK
- 0001398733
- Primary document
- https://www.sec.gov/Archives/edgar/data/1398733/000139873326000030/aqst-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aquestive Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $14.4M | - | - |
| Cost Of Revenue | $3.5M | - | - |
| Operating Income | $-4.2M | - | - |
| Net Income | $-8.1M | - | - |
| Eps Basic | -0.07 | - | - |
| Eps Diluted | -0.07 | - | - |
| Cash And Equivalents | $110.7M | - | - |
| Total Assets | $141.1M | - | - |
| Total Liabilities | $175.2M | - | - |
| Shareholders Equity | $-34.1M | - | - |
| Operating Cash Flow | $-14.8M | - | - |
| Capital Expenditures | $52,000 | - | - |